TY - JOUR
T1 - C4 article
T2 - Implications of COVID-19 in transplantation
AU - Contributors to the C4 article
AU - Aaron, Justin G.
AU - Abbo, Lilian M.
AU - Alconchel, Felipe
AU - Amarelli, Cristiano
AU - Anjan, Shweta
AU - Ardura, Monica I.
AU - Azar, Marwan M.
AU - Azzi, Jamil
AU - Baddley, John W.
AU - Balliet, Wendy
AU - Bellini, Maria Irene
AU - Blumberg, Emily
AU - Blumenthal, James A.
AU - Bruschwein, Heather M.
AU - Danziger-Isakov, Lara
AU - Demekhin, Valerie
AU - Dulek, Daniel E.
AU - Ferreira, Gustavo Fernandes
AU - Gambella, Alessandro
AU - Giorgakis, Emmanouil
AU - Gitman, Melissa R.
AU - Goff, Kristina L.
AU - Green, Michael
AU - Greenwald, Melissa A.
AU - Hand, Jonathan
AU - Hemmersbach-Miller, Marion
AU - Humar, Atul
AU - Ison, Michael G.
AU - Jaramillo, Andrés
AU - Jesse, Michelle T.
AU - Kotton, Camille Nelson
AU - Kronsnoble, Kristin
AU - Kumar, Deepali
AU - La Hoz, Ricardo M.
AU - Lentine, Krista
AU - Lopez, Santiago M.C.
AU - Miko, Benjamin A.
AU - Mohan, Sumit
AU - Murakami, Naoka
AU - Niles, Patti
AU - Nolan, Annelise
AU - Nonterah, Camilla W.
AU - Park, Jeong M.
AU - Madan, Rebecca Pellett
AU - Pereira, Marcus R.
AU - Cortes Villalobos, Armelle Perez
AU - Pilch, Nicole
AU - Potter, Lisa M.
AU - Rodrigue, James R.
AU - Rodrigue, James R.
N1 - Publisher Copyright:
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons
PY - 2021/5
Y1 - 2021/5
N2 - A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS-CoV-2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric-specific issues are also discussed. Strategies for the psychological well-being of patients and providers are also imperative, in addition to future research priorities for transplantation.
AB - A novel coronavirus has had global impact on individual health and health care delivery. In this C4 article, contributors discuss various aspects of transplantation including donor and recipient screening, management of infected patients, and prevention of coronavirus disease (COVID). Donor screening with SARS-CoV-2 nucleic acid testing (NAT) close to the time of procurement is recommended. Many programs are also screening all potential recipients at the time of admission. The management of COVID has evolved with remdesivir emerging as a new potential option for transplant recipients. Dexamethasone has also shown promise and convalescent plasma is under study. Prevention strategies for transplant candidates and recipients are paramount. Pediatric-specific issues are also discussed. Strategies for the psychological well-being of patients and providers are also imperative, in addition to future research priorities for transplantation.
KW - clinical research/practice
KW - infection and infectious agents
KW - infection and infectious agents – viral
KW - infectious disease
KW - organ transplantation in general
UR - http://www.scopus.com/inward/record.url?scp=85106069148&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85106069148&partnerID=8YFLogxK
U2 - 10.1111/ajt.16346
DO - 10.1111/ajt.16346
M3 - Article
C2 - 33040483
AN - SCOPUS:85106069148
SN - 1600-6135
VL - 21
SP - 1801
EP - 1815
JO - American Journal of Transplantation
JF - American Journal of Transplantation
IS - 5
ER -